1. Home
  2. AMPL vs CRVS Comparison

AMPL vs CRVS Comparison

Compare AMPL & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

SELL

Current Price

$15.85

Market Cap

1.6B

Sector

Technology

ML Signal

SELL

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$9.85

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPL
CRVS
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
AMPL
CRVS
Price
$15.85
$9.85
Analyst Decision
Buy
Strong Buy
Analyst Count
12
8
Target Price
$14.77
★ $33.14
AVG Volume (30 Days)
★ 1.6M
1.2M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
11.84
★ 48.04
EPS
N/A
★ N/A
Revenue
★ $343,214,000.00
N/A
Revenue This Year
$19.51
N/A
Revenue Next Year
$15.89
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.68
N/A
52 Week Low
$5.51
$6.39
52 Week High
$16.18
$26.95

Technical Indicators

Market Signals
Indicator
AMPL
CRVS
Relative Strength Index (RSI) 69.43 32.53
Support Level $6.05 $6.39
Resistance Level N/A $13.73
Average True Range (ATR) 0.58 0.60
MACD 0.09 -0.08
Stochastic Oscillator 91.04 21.18

Price Performance

Historical Comparison
AMPL
CRVS

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: